Clinical trial
Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive…
NCT00248365 · Kiadis Pharma, Industry · Completed
Key facts
| NCT number | NCT00248365 |
|---|---|
| Title | Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD) |
| Official title | Safety, Biological and Clinical Efficacy of Two Intensity Levels of Theralux Extracorporeal Photochemotherapy in Subjects With Extensive Chronic GvHD Refractory or Intolerant to Standard Therapy: A Randomized, Open-label Phase I/II Clinical Trial |
| Lead sponsor | Kiadis Pharma, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Graft vs Host Disease |
| Intervention type | Biological |
| Interventions | Theralux extracorporeal photochemotherapy |
| Enrollment | 20 |
| Start date | Nov 1, 2005 |
| Completion | Aug 1, 2007 |
| First posted | Nov 4, 2005 |
| Last update posted | Feb 25, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: